𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis

✍ Scribed by Mingming Zhu; Xitao Xu; Fang Nie; Jinlu Tong; Shudong Xiao; Zhihua Ran

Publisher
Springer
Year
2011
Tongue
English
Weight
259 KB
Volume
26
Category
Article
ISSN
0179-1958

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Optimal apheresis treatment volume for t
Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with cellsorba in patients with active ulcerative colitis
✍ Ken Fukunaga; Koji Kamikozuru; Yoko Yokoyama; Nobuyuki Hida; Yoshio Ohda; Naohis πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 165 KB

## Abstract **Background**: Leukocytapheresis (LCAP) is used as an adjunct therapy for patients with active ulcerative colitis (UC). Although, LCAP is routinely performed at 3,000 mL per session, we were interested to see that if this can be replaced with bodyweight (BW) adjusted volume. **Methods*

Mucosal healing in patients with ulcerat
Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: A prospective cohort study
✍ Takayuki Yamamoto; Satoru Umegae; Koichi Matsumoto πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 270 KB

Background: During active ulcerative colitis (UC), vast numbers of granulocytes, monocytes/macrophages (GM) infiltrate the mucosal tissue and can potentially exacerbate inflammation and injury. Accordingly, we were interested to see if selective depletion of GM by adsorption (GMA) impacts mucosal he

Efficacy and safety of tacrolimus in ref
Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: A single-center experience
✍ Aaron Benson; Terrence Barrett; Marshall Sparberg; Alan L. Buchman πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 2 views

## Background: The published experience regarding the use of tacrolimus in crohn's disease (cd) and ulcerative colitis (uc) refractory to more commonly used medical therapy has been fairly limited. our objective was to describe our experience with its use in a cohort of patients which, to our knowl